Telmikind Trio 6.25mg Tablet belongs to the therapeutic classification of Angiotensin II Receptor Blockers, Calcium channel blocking agents. The primary composition for this medicine is Chlortalidone 6.25 MG, Cilnidipine 10 MG, Telmisartan 40 MG.

If you are allergic to Telmikind Trio 6.25 Tablet 10's or any other medicines, please tell your doctor. Telmikind Trio 6.25 Tablet 10's is not recommended for children below 18 years of age. If you are pregnant or breastfeeding, avoid taking Telmikind Trio 6.25 Tablet 10's and consult a doctor. If you are about to take anesthesia or undergo any surgery, you are advised to inform your doctor that you are taking Telmikind Trio 6.25 Tablet 10's. Avoid taking Telmikind Trio 6.25 Tablet 10's if you have low levels of sodium or potassium in blood, gout, kidney stones, Addison’s disease (adrenal gland does not produce sufficient steroids), high blood levels of calcium, severe liver or kidney problems. Drive only if you are alert as Telmikind Trio 6.25 Tablet 10's may cause dizziness or tiredness. You are recommended to avoid alcohol consumption with Telmikind Trio 6.25 Tablet 10's as it may increase the risk of low blood pressure.